Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2005
08/04/2005US20050171187 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate
08/04/2005US20050171183 Indole-type inhibitors of p38 kinase
08/04/2005US20050171181 Histamine-3 receptor modulators
08/04/2005US20050171175 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
08/04/2005US20050171164 5-substituted-alkylaminopyrazole derivatives as pesticides
08/04/2005US20050171162 Crystals of benzimidazole compounds
08/04/2005US20050171158 1-(sulfonylaminomethylcarbonyl)-4-cyclohexylpiperidine compounds such as N-[1-(R)-(4-chlorobenzyl)-2-(4-cyclohexyl-4-[1,2,4]triazol-1-ylmethyl-piperidin-1-yl)-2-oxo-ethyl]-methanesulfonamide; various diseases and disorders such as weight control, eating disorders
08/04/2005US20050171156 Prodrugs of potassium channel inhibitors
08/04/2005US20050171154 Carboxylic acid amides
08/04/2005US20050171153 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases
08/04/2005US20050171146 Non-peptidic BRS-3 agonists
08/04/2005US20050171143 selective Chemoattractant receptor-homologous molecule expressed on Th2 cells ( CRTH2 receptor) antagonist; activities for eosinphil and basophil infiltration; indol/carbazol-sulfonamide derivatives; antiallergenic agent; asthma, allergic rhinitis and dermatitis, polyarteritis, autoimmune disease
08/04/2005US20050171140 Prevent cholesterol biosynthesis; moderating blood serum lipid ; antidiabetic agents; obesity; hypotensive agents; osteoporosis; Alzheimer's disease; cardiovascular disorders; hormone replacement therapy
08/04/2005US20050171136 Modulators of the glucocorticoid receptor and method
08/04/2005US20050171134 such as 4-[4-(1-Amino-1-methylethyl)phenyl]-5-chloro-N-[4-(2-hydroxyethyl)phenyl]pyrimidine-2-amine used as tyrosine kinase inhibitors, for prophylaxis disease states associated with angiogenesis
08/04/2005US20050171132 Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (GHS-R) antagonists
08/04/2005US20050171131 Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists
08/04/2005US20050171123 Quinazoline derivatives as medicaments
08/04/2005US20050171118 Central nervous system, gastrointestinal and psycological disorders; such as 3-(4-chlorobenzenesulfonyl)-2-methyl-7-piperazin-1-yl-1H-indole; synthesis
08/04/2005US20050171117 Preparation of pharmaceutical salts
08/04/2005US20050171111 E.g., 4-[[5-[[4-(3-chlorophenyl)-1,2-dihydro-2-oxo-6-quinolinyl]hydroxymethyl]-1H-imidazol-1-yl]methyl]-benzonitrile; prevents the membrane attachment of p21ras and blocks the aberrant growth of ras-transformed tumors
08/04/2005US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors
08/04/2005US20050171101 Neurodegenerative diseases; diseases ascribed by NMDA- and NO-induced neurotoxicity ; ischemia; antiinflammatory; anticancer; antidiabetic; 2-{3-[4-Phenyl-3,6-dihydro-1(2H)-pyridyl]propyl}-6(5H)-phenanthridinone
08/04/2005US20050171098 MCH antagonists and their use in the treatment of obesity
08/04/2005US20050171096 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
08/04/2005US20050171092 Chemical compounds
08/04/2005US20050171085 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
08/04/2005US20050171057 Pantoprazole cyclodextrin inclusion complexes
08/04/2005US20050170999 Excitatory amino acid receptor antagonists
08/04/2005CA2554233A1 Substituted n-cyclohexyl imidazolinones having an mch-modulatory effect
08/04/2005CA2554188A1 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
08/04/2005CA2553969A1 Vanilloid receptor ligands and their use in treatments
08/04/2005CA2553773A1 N-type calcium channel blockers
08/04/2005CA2553242A1 2,6-disubstituted piperidines as modulators of chemokine receptor activity
08/04/2005CA2553232A1 Substituted heterocyclic compounds and methods of use
08/04/2005CA2552419A1 Azadecalin glucocorticoid receptor modulators
08/04/2005CA2552362A1 4-aryl piperidines
08/03/2005EP1559714A1 Process for the preparation of 2-alkyl-3-aminothiophene derivatives and 3-aminothiophene derivatives
08/03/2005EP1559710A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV, process for their preparation and their use
08/03/2005EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same
08/03/2005EP1559428A1 Receptor regulator
08/03/2005EP1558608A1 Oxindole substituted piperazine derivatives
08/03/2005EP1558606A2 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
08/03/2005EP1558601A1 Selected cgrp antagonists, method for production and use thereof as medicament
08/03/2005EP1558600A1 Selected cgrp antagonists, method for production and use thereof as medicament
08/03/2005EP1558599A2 Heteroarylpiperidine modulators of chemokine receptor activity
08/03/2005EP1558598A1 Triazole compounds for the treatment of dysmenorrhoea
08/03/2005EP1558583A1 Novel phenylethanolamine derivatives and the use of the same as beta-3-agonists
08/03/2005EP1558581A2 Triazolone and triazolethione derivatives
08/03/2005EP1558580A2 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
08/03/2005EP1558579A1 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
08/03/2005EP1558578A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds
08/03/2005EP1558576A2 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
08/03/2005EP1558341A2 Transcription factor modulating compounds and methods of use thereof
08/03/2005EP1558260A2 Quinazolinone compounds as calcilytics
08/03/2005EP1558255A2 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease
08/03/2005EP1558253A2 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
08/03/2005EP1558250A1 Gamma-aminoamide modulators of chemokine receptor activity
08/03/2005EP1558246A1 Proline derivatives having affinity for the calcium channel alpha-2-delta subunit
08/03/2005EP1558083A2 Compounds, compositions, and methods
08/03/2005EP1438307B1 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
08/03/2005EP1436284B1 Synthesis of 4- (z)-(4-bromophenyl)(ethoxyimino)methyl]-1'- 2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'methyl-1,4'bipiperidine
08/03/2005EP1228059B1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof
08/03/2005EP1142890B1 Aminopyrazole derivatives
08/03/2005EP1071671B1 Triazolones with a neuroprotective action
08/03/2005EP1016661B1 2,6-dichloro-4-pyridinemethanol derivatives as agricultural chemicals
08/03/2005CN1649885A Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
08/03/2005CN1649865A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/03/2005CN1649864A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
08/03/2005CN1649863A Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
08/03/2005CN1649862A Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics
08/03/2005CN1649850A Cyclic compound, process for producing the same, and pest control agent
08/03/2005CN1649849A Tachykinin receptor antagonists
08/03/2005CN1649842A 2, 6-quinolinyl and 2, 6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
08/03/2005CN1649840A Non-peptidic BRS-3 agonists
08/03/2005CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
08/03/2005CN1649830A Substituted aryl ketones
08/03/2005CN1649587A Use of epothilones in the treatment of brain diseases associated with proliferative processes
08/03/2005CN1213045C Tyrosine kinase inhibitors
08/03/2005CN1213044C Amine and amide derivatives as ligands for neuropeptide YY5 receptor useful in treatment of obesity and other disorders
08/03/2005CN1213040C Serine protese inhibitors
08/03/2005CN1213038C Benzophenones as inhibitors of reverse transcriptase
08/03/2005CN1213031C Method for producing 5-aryl nicotinaldehydes
08/03/2005CN1213028C Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use
08/03/2005CN1213026C Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
08/03/2005CN1213025C 硫代酰胺衍生物 Thioamide derivatives
08/03/2005CN1213022C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
08/03/2005CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
08/03/2005CN1212839C Use of substituted pyrazoles in preparing medicine for treating allergies
08/02/2005US6924302 Nitrogen compounds such as 5-amino-3-[[4-(aminosulfonyl)phenyl]amino]-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide, used as cyclin dependent and tyrosine kinase inhibitors, for prophylaxis of tumors
08/02/2005US6924297 Naphathalene derivatives which bind to the EP4 receptor
08/02/2005US6924296 Antithrombotic agents
08/02/2005US6924294 A 6-(2-(1(2)H-tetrazol-5-yl)-phenylamino)-1,2,3,4,4a,5,6,7,8,8a -decahydroisoquinoline 3-carboxylic acid derivatives; for treating neurological disorders and neurodegenerative diseases, pain and migraine
08/02/2005US6924290 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders
08/02/2005US6924289 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc.
08/02/2005US6924287 Respiratory syncytial virus replication inhibitors
08/02/2005US6924285 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
08/02/2005US6924284 PARP inhibitors
08/02/2005US6924278 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases
08/02/2005US6924154 Hydrophilic chemilumescent acridinium labeling reagents
1 ... 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 ... 1080